Core acupoint selection strategies and multifactorial analysis for acute musculoskeletal pain - Top-Institutions - MDSpire

Core acupoint selection strategies and multifactorial analysis for acute musculoskeletal pain

  • By

  • Yide Fang

  • Ran Xiao

  • Yanlan Kang

  • Cheng Chen

  • Zhenghang Bian

  • Ruirui Xue

  • Bing Shu

  • Jinhai Xu

  • Wen Mo

  • May 7, 2026

  • 0 min

Share

Top Institutions in Orthopedic Medicine

Brief introduction explaining scope and methodology.

  • #1

    university hospital
    university hospital

    Unknown City, Unknown State

    Key Differentiators

    • Pain Management

  • #2

    American Academy of Pain Medicine (AAPM)
    American Academy of Pain Medicine (AAPM)

    Unknown City, Unknown State

    Key Differentiators

    • Pain Management

  • #3

    ADA Science & Research Institute
    ADA Science & Research Institute

    Unknown City, Unknown State

    Key Differentiators

    • Pain Management

  • #4

    Stanford Pain Relief Innovations Lab
    Stanford Pain Relief Innovations Lab

    Stanford, California

    Key Differentiators

    • Pain Management

  • #5

    Harvard Medical Device Innovation Initiative
    Harvard Medical Device Innovation Initiative

    Cambridge, Massachusetts

    Key Differentiators

    • Pain Management

Original Source(s)

Core acupoint selection strategies and multifactorial analysis for acute musculoskeletal pain

  • by Yide Fang, Ran Xiao, Yanlan Kang, Cheng Chen, Zhenghang Bian, Ruirui Xue, Bing Shu, Jinhai Xu, Wen Mo

  • May 7, 2026

Related Content

Precuneus hyperexcitability mediates inflammatory-driven pain hypersensitivity following sleep disruption: a multimodal neuroimaging study

Top 10 States for Physician-Owned Hospitals

These 10 states make it more practical for physicians to participate in hospital ownership by aligning statutory structure, corporate practice of medicine rules, and population trends.

RA Prescribing Patterns Shift Over 15 Years

An aging Japanese cohort with rheumatoid arthritis saw increasing use of targeted synthetic therapies as glucocorticoid use declined.